Metraipolis › archive › dc_13a13ee168bf
Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review — Europe PMC PMID:41488631
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488631
- DOI
- 10.3389/fimmu.2025.1664587
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T12:42:37.431Z
- SHA-256 of the archived text
605420de94073a99155e260d6965773f86fbe19fb7a2295b67cb9d9f98f6c29e- Stable URL of this page
https://metraipolis.com/documento/dc_13a13ee168bf
How to cite
Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review — Europe PMC PMID:41488631 — Europe PMC (en), https://europepmc.org/article/MED/41488631 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_13a13ee168bf (Metraipolis archive dc_13a13ee168bf, sha256 605420de94073a99155e260d6965773f86fbe19fb7a2295b67cb9d9f98f6c29e)
BibTeX
@misc{dc13a13ee168bf,
title = {Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review — Europe PMC PMID:41488631},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488631},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_13a13ee168bf; sha256 605420de94073a99155e260d6965773f86fbe19fb7a2295b67cb9d9f98f6c29e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488631. Agents can read the archived copy with the MCP tool read_document.